Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation.
Allergy
; 75(5): 1188-1204, 2020 05.
Article
in En
| MEDLINE
| ID: mdl-31838750
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-13
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Allergy
Year:
2020
Document type:
Article
Affiliation country:
United States
Country of publication:
Denmark